Literature DB >> 17195844

Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self.

Je-Wook Lee1, Mathieu Epardaud, Jing Sun, Jessica E Becker, Alexander C Cheng, Ai-ris Yonekura, Joan K Heath, Shannon J Turley.   

Abstract

The intestinal epithelium functions to absorb nutrients and to protect the organism against microbes. To prevent autoimmune attack on this vital tissue, T cell tolerance to intestinal self-antigens must be established. Central tolerance mechanisms involve medullary thymic epithelial cells (mTECs), which use endogenously expressed peripheral-tissue antigens (PTAs) to delete self-reactive thymocytes. The prevailing model for the induction of peripheral tolerance involves cross-presentation of tissue antigens by quiescent dendritic cells. Here we show that lymph node stromal cells present endogenously expressed PTAs to T cells. Moreover, antigen presentation by lymph node stroma is sufficient to induce primary activation and subsequent tolerance among CD8(+) T cells. Thus, lymph node stromal cells are functionally akin to mTECs and provide a direct strategy for purging the peripheral repertoire of self-reactive T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195844     DOI: 10.1038/ni1427

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  171 in total

1.  Langerhans cells are precommitted to immune tolerance induction.

Authors:  Elena Shklovskaya; Brendan J O'Sullivan; Lai Guan Ng; Ben Roediger; Ranjeny Thomas; Wolfgang Weninger; Barbara Fazekas de St Groth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 2.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

Review 3.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 4.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 5.  The role of Aire in clonal selection.

Authors:  Ruth T Taniguchi; Mark S Anderson
Journal:  Immunol Cell Biol       Date:  2010-11-16       Impact factor: 5.126

6.  Cross-differentiation from the CD8 lineage to CD4 T cells in the gut-associated microenvironment with a nonessential role of microbiota.

Authors:  Jen Bon Lui; Priyadharshini Devarajan; Sarah A Teplicki; Zhibin Chen
Journal:  Cell Rep       Date:  2015-01-29       Impact factor: 9.423

Review 7.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

8.  Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cells.

Authors:  James M Gardner; Todd C Metzger; Eileen J McMahon; Byron B Au-Yeung; Anna K Krawisz; Wen Lu; Jeffrey D Price; Kellsey P Johannes; Ansuman T Satpathy; Kenneth M Murphy; Kristin V Tarbell; Arthur Weiss; Mark S Anderson
Journal:  Immunity       Date:  2013-08-29       Impact factor: 31.745

9.  Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytes.

Authors:  Aikaterini Hatzioannou; Saba Nayar; Anastasios Gaitanis; Francesca Barone; Constantinos Anagnostopoulos; Panayotis Verginis
Journal:  Oncoimmunology       Date:  2016-07-29       Impact factor: 8.110

Review 10.  Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.

Authors:  Lisa S Westerberg; Christoph Klein; Scott B Snapper
Journal:  Curr Opin Immunol       Date:  2008-11-12       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.